My country has issued policies in many places to vigorously support the development of the cell therapy industry!

        In recent years, relevant policies have been intensively introduced at the national and local levels to support the development of stem cells. In 2021, the policy dividend will continue to be supported, and local governments have introduced policies to promote cell therapy!
        The National Health Commission clearly stated that it encourages and supports the research, transformation and industrial development of stem cells and immune cells.
        On February 9, 2021, the National Health Commission released the "Reply to Recommendation No. 4371 of the Third Session of the Thirteenth National People's Congress" on its official website.
        The reply letter clearly stated: Our committee has always encouraged and supported the research, transformation and industrial development of stem cells and immune cells. Cell preparations such as stem cells and immune cells have obvious pharmaceutical properties. The national drug regulatory authority has formulated supporting policies for relevant preparations to pass drug approval, which can be quickly and widely used after approval, which is not only conducive to ensuring medical quality and safety, but also conducive to industrialization and high-quality development.

01
Tianjin Free Trade Zone intends to use medical technology access to promote the clinical application of low- and medium-risk cell therapy products

        On April 21, Tianjin Radio and Television Station reported: "Experimenting the system for the country" is a duty written into the genes of the Tianjin Pilot Free Trade Zone. Beginning at the end of last year, led by the Free Trade Zone Policy Research Center, it has conducted joint investigations with many “national” scientific research institutions and academician workstations in Beijing, Tianjin and Hebei, and conducted feasibility demonstrations for application operations; Departments, etc., jointly organize industry regulatory organizations to promote low- and medium-risk cell therapy products, access medical technology, and carry out clinical applications. After more than half a year of demonstration, the "Report on the Pilot Test of Cell Therapy in Tianjin Free Trade Zone" has been drafted and submitted to the Ministry of Commerce. Once the pilot is successful, patients can directly enjoy cell diagnosis and treatment methods in the Tianjin Free Trade Pilot Zone and the Linkage Innovation Zone, and scientific research institutions can also let go of research and realize clinical transformation and application more quickly.

02
The Dalian Free Trade Zone will build a "Gene Cell Therapy Pilot Demonstration Zone" to promote cell therapy in the Dalian Free Trade Zone.

        On April 19, the Dalian Free Trade Zone and Dalian Medical University signed a framework agreement to jointly build the "Dalian Gene Cell Therapy Pilot Zone" in the Dalian Free Trade Zone. According to the agreement, the two parties will build a cell therapy clinical medical center to promote cell therapy in the Dalian Free Trade Zone. Give full play to the advantages of Dalian Medical University's disciplines, high-level talents and high-level medical care, and focus on in-depth research in the fields of cell therapy, genetic testing, and drug research and development. Explore the establishment of a research and development and achievement transformation model adapted to the characteristics of the Dalian Free Trade Area, strive to realize the transformation and application of key core technologies in the area, and actively carry out foreign cooperation in gene cell therapy.

03
Beijing Health Commission: Do a good job in the preliminary review of stem cell and somatic cell clinical research institutions and project filings in 2021, and provide important evidence-based support for the promotion of stem cells into clinical applications

        On March 17, the Beijing Municipal Health Commission released the "Key Points of Beijing Municipal Health Science and Education Work in 2021" on its official website. The main points clearly stated: do a good job in the preliminary review of stem cell and somatic cell clinical research institutions and project filings, strengthen policy consulting services and pre-application counseling, support filing institutions and enterprises to cooperate in clinical research, and provide an important basis for promoting stem cells to enter clinical applications.

04
Director Luo Wenzhi presided over the "Shenzhen Special Economic Zone Cell and Gene Industry Promotion Regulations (Draft)" Legislative Solicitation Forum

        On March 12, Director Luo Wenzhi presided over a forum for soliciting opinions on the legislation of "Shenzhen Special Economic Zone Cell and Gene Industry Promotion Regulations (Draft)". At the meeting, it was proposed that the first is to emancipate the mind, try first, give play to the role of legislation to lead and promote protection, so as to make good use of the legislative power of the special economic zone and the reform pilot power granted by the state without conflicting with the basic principles of national laws. There must be breakthroughs in thinking and policy measures. The second is to rely on enterprises to provide good services to develop cell and gene industries. The financial and related industry authorities must focus on supporting enterprises to continuously increase R&D and innovation, accelerate breakthroughs in key technologies in key areas, and achieve high-quality industrial development by improving product quality.

05
Kunming High-tech Zone issued 16 policies and measures to promote the innovative development of cell industry clusters

        On March 11, the Kunming National High-tech Industrial Development Zone (hereinafter referred to as "Kunming High-tech Zone") cell industry policy release conference and the opening ceremony of the Kunming High-tech Zone Cell Industry Alliance were held. The conference also issued the "Kunming High-tech Zone Promoting Cell Industry Cluster Innovation Development of Several Policies (for Trial Implementation). The policy clearly states: 16 policy measures have been issued in seven areas: supporting the development of cell industry clusters, promoting the standardization of the cell industry, and supporting the construction of cell industry platforms. The main points of the policy are the Cell Industry Cluster Innovation Park in Kunming High-tech Zone as the core area and main Gathering areas, focus on promoting the development of cell industry clusters.

06       
Hangzhou Xiaoshan Area of Zhejiang Free Trade Zone will focus on opening up the approval authority for the clinical and commercialization of cell therapy and gene therapy

        On February 19, the People's Government of Xiaoshan District, Hangzhou City officially released the "Construction Plan for Xiaoshan Block in Hangzhou Area of China (Zhejiang) Pilot Free Trade Zone" on its official website. The plan clearly puts forward: Explore the first trial of biomedicine. Promote advance trials in biomedicine review and approval, import and export customs clearance, medical services, data and talent element guarantees. Focus on opening up the clinical and commercial approval authority for cell therapy and gene therapy, and explore the establishment of a green channel in the process of application and testing of cell and gene therapy drugs. Support the entry of overseas innovative medical technologies used in clinical research, and pilot the establishment of foreign professional institutions such as foreign-funded medical institutions, health and medical insurance institutions, and health management institutions.